119 related articles for article (PubMed ID: 2419148)
1. Anti-platelet action of an anti-allergic agent, N-(3',4'-dimethoxycinnamoyl)anthranilic acid (tranilast).
Iwasa Y; Iwasa T; Matsui K; Yoshimura T; Tanaka N; Miyazaki K
Eur J Pharmacol; 1986 Jan; 120(2):231-4. PubMed ID: 2419148
[TBL] [Abstract][Full Text] [Related]
2. The mechanism for the inhibitory action of N-(3',4'-dimethoxycinnamoyl)anthranilic acid (tranilast) on the release reaction in platelets.
Iwasa Y; Iwasa T; Yoshimura T; Matsui K; Onaya T
Eur J Pharmacol; 1988 Jul; 152(1-2):135-9. PubMed ID: 2463171
[TBL] [Abstract][Full Text] [Related]
3. N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.
Platten M; Wild-Bode C; Wick W; Leitlein J; Dichgans J; Weller M
Int J Cancer; 2001 Jul; 93(1):53-61. PubMed ID: 11391621
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of proliferative responses of lymphocytes to food antigens by an anti-allergic drug, N(3',4'-dimethoxycinnamoyl) anthranilic acid (Tranilast) in children with atopic dermatitis.
Kondo N; Fukutomi O; Kameyama T; Orii T
Clin Exp Allergy; 1992 Apr; 22(4):447-53. PubMed ID: 1377091
[TBL] [Abstract][Full Text] [Related]
5. Tranilast, an anti-allergic drug, possesses antagonistic potency to angiotensin II.
Jin D; Takai S; Shiota N; Miyazaki M
Eur J Pharmacol; 1998 Nov; 361(2-3):199-205. PubMed ID: 9865509
[TBL] [Abstract][Full Text] [Related]
6. Study of the mechanism of inhibitory action of tranilast on chemical mediator release.
Komatsu H; Kojima M; Tsutsumi N; Hamano S; Kusama H; Ujiie A; Ikeda S; Nakazawa M
Jpn J Pharmacol; 1988 Jan; 46(1):43-51. PubMed ID: 2452912
[TBL] [Abstract][Full Text] [Related]
7. Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts.
Yamada H; Tajima S; Nishikawa T; Murad S; Pinnell SR
J Biochem; 1994 Oct; 116(4):892-7. PubMed ID: 7533764
[TBL] [Abstract][Full Text] [Related]
8. The mechanism involved in the inhibitory action of tranilast on collagen biosynthesis of keloid fibroblasts.
Suzawa H; Kikuchi S; Arai N; Koda A
Jpn J Pharmacol; 1992 Oct; 60(2):91-6. PubMed ID: 1282576
[TBL] [Abstract][Full Text] [Related]
9. Cell action mechanism of tranilast--effect on the expression of HLA-class II antigen.
Kawano Y; Noma T
Int J Immunopharmacol; 1993 May; 15(4):487-500. PubMed ID: 7690011
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory action of tranilast, an anti-allergic drug, on the release of cytokines and PGE2 from human monocytes-macrophages.
Suzawa H; Kikuchi S; Ichikawa K; Koda A
Jpn J Pharmacol; 1992 Oct; 60(2):85-90. PubMed ID: 1282575
[TBL] [Abstract][Full Text] [Related]
11. Suppressive effects of the anti-allergic drugs, tranilast and azelastine, on the lysophosphatidylserine-dependent activation of rat mast cells.
Hara K; Komatsu H; Tsutsumi N; Ujiie A; Ikeda S; Kobayashi T; Kudo I; Inoue K
Biol Pharm Bull; 1994 Aug; 17(8):1121-3. PubMed ID: 7529613
[TBL] [Abstract][Full Text] [Related]
12. Treatment of linear localized scleroderma with the anti-allergic drug, tranilast.
Taniguchi S; Yorifuji T; Hamada T
Clin Exp Dermatol; 1994 Sep; 19(5):391-3. PubMed ID: 7525127
[TBL] [Abstract][Full Text] [Related]
13. The effect of a new anti-inflammatory agent, the ethoxy methyl ester of N-(2,6-dichloro-m-tolyl)-anthranilic acid (A3), on platelet behaviour "in vivo" and "in vitro".
Fregnan GB; Chieli T
Pharmacol Res Commun; 1975 Jun; 7(3):239-46. PubMed ID: 1144497
[No Abstract] [Full Text] [Related]
14. Effect of tranilast on proliferation, collagen gel contraction, and transforming growth factor beta secretion of retinal pigment epithelial cells and fibroblasts.
Yasukawa T; Kimura H; Dong J; Tabata Y; Miyamoto H; Honda Y; Ogura Y
Ophthalmic Res; 2002; 34(4):206-12. PubMed ID: 12297693
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of tranilast on prostaglandin D synthetase.
Ikai K; Ujihara M; Fujii K; Urade Y
Biochem Pharmacol; 1989 Aug; 38(16):2673-6. PubMed ID: 2475113
[TBL] [Abstract][Full Text] [Related]
16. Solitary mastocytoma treated with tranilast.
Katoh N; Hirano S; Yasuno H
J Dermatol; 1996 May; 23(5):335-9. PubMed ID: 8675824
[TBL] [Abstract][Full Text] [Related]
17. [Effect of tranilast, an anti-allergic drug, on the human keloid tissues].
Suzawa H; Kikuchi S; Ichikawa K; Arai N; Tazawa S; Tsuchiya O; Momose Y; Shibata N; Sugimoto C; Hamano S
Nihon Yakurigaku Zasshi; 1992 Apr; 99(4):231-9. PubMed ID: 1376711
[TBL] [Abstract][Full Text] [Related]
18. Mast cell degranulation and its inhibition by an anti-allergic agent tranilast. An electron microscopic study.
Nishigaki T
Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(5):311-22. PubMed ID: 2457982
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of some natural products on the activation of hyaluronidase and their anti-allergic actions.
Kakegawa H; Matsumoto H; Satoh T
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1439-42. PubMed ID: 1382876
[TBL] [Abstract][Full Text] [Related]
20. [Effect of tranilast on the release of slow reacting substance of anaphylaxis (SRS-A) and contraction of the smooth muscle].
Komatsu H; Ujiie A; Naito J
Nihon Yakurigaku Zasshi; 1983 Jul; 82(1):47-55. PubMed ID: 6194082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
